ReShape Lifesciences prices $6M public offering of 2.6M units at $2.33/unit

Vyome Holdings, Inc

Gross proceeds ~$6M from offering of 2,575,107 units at $2.33/unit; closed Feb 18, 2025.
Each unit consists of one common share (or pre-funded warrant) and one warrant to buy one share at $5.83, subject to stockholder approval.
Warrants have reset mechanism (floor $1.25) and alternative cashless exercise (1.2x shares); expire after merger or 60 days post approval.
Net proceeds for general corporate purposes, merger with Vyome, asset sale to Ninjour; up to 50% to prepay Ascent Partners note.
Maxim Group LLC acted as sole placement agent with 7% cash fee and 128,755 placement agent warrants.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.